Cleveland Clinic and Harvard Medical School provided input on psychedelic drug regulation.
1 report, 1 independent
Updated Thu 00:00
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Cleveland Clinic and Harvard Medical School provided input on psychedelic drug regulation.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
- FDA
-
Cleveland Clinic
nonprofit multispecialty academic medical center based in Cleveland, Ohio, United States
Nothing else this week.
-
Harvard Medical School
medical school in Boston, Massachusetts
Related events
- An Executive Order has been issued mandating accelerated research into psychedelic therapies through partnerships between various bodies.
- Marty Makary serves as FDA Commissioner overseeing drug approvals and advocates for psychedelic therapies in clinical settings.
- Agencies (FDA and DEA) implement a regulatory shift concerning cannabis.
- Ohio and Pennsylvania regulate cannabis and kratom while the FDA advances government-funded clinical trials for ibogaine research.
- Both the FDA and the Drug Enforcement Administration regulate stimulant medications.